Sotera Health Company (SHC) vs Travere Therapeutics, Inc. (TVTX)

A side-by-side comparison of Sotera Health Company and Travere Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — SHC vs TVTX

growth of $100 · dividends reinvested · last 6y
SHC -26.1% (-4.9%/yr)TVTX +136.7% (+15.4%/yr)TVTX compounded faster over this window
100200Start $100202120222023202420252026$74$237
SHC TVTX

SHC vs TVTX: by the numbers

  • •SHC is the larger company ($5.23B vs $5.19B market cap).
  • •SHC is profitable (13.44% net margin) while TVTX runs a net loss (-7.35%).
  • •TVTX grew revenue faster over the past five years (23.71% vs 6.66% CAGR).

Metrics side by side

Valuation

MetricSHCTVTX
P/E ratio32.07N/A
Forward P/E18.64N/A
P/S ratio4.308.78
P/B ratio7.86211.81
EV / EBITDA12.48248.47
FCF yield2.15%0.99%

Profitability

MetricSHCTVTX
Gross margin54.72%94.41%
Operating margin36.24%-6.84%
Net margin13.44%-7.35%
ROE24.56%-177.24%
ROIC8.80%-6.19%

Growth (annualized)

MetricSHCTVTX
Revenue CAGR (5Y)6.66%23.71%
FCF CAGR (5Y)17.34%N/A
Total return CAGR (5Y)-6.39%17.83%

Frequently asked

Which has grown faster, SHC or TVTX?
Over the past five years, TVTX grew revenue faster — SHC at a 6.66% CAGR versus TVTX at 23.71%.
Is SHC or TVTX more profitable?
SHC runs the higher net margin — SHC at 13.44% versus TVTX at -7.35%.
How have SHC and TVTX total returns compared?
Over the past 5 years, SHC delivered -6.39% and TVTX delivered 17.83% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.